Caisse de Depot et Placement du Quebec (CDPQ)’s Sarepta Therapeutics SRPT Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-66,000	Closed	-$1.27M	–	604
2025 Q3	$1.27M	Buy	+66,000	New	+$1.18M	﹤0.01%	514
2025 Q1	–	Sell	-19,000	Closed	-$2.31M	–	648
2024 Q4	$2.31M	Buy	+19,000	New	+$2.33M	﹤0.01%	474
2022 Q2	–	Sell	-32,800	Closed	-$2.56M	–	654
2022 Q1	$2.56M	Sell	32,800 -9,800	-23%	-$750K	0.01%	486
2021 Q4	$3.84M	Buy	+42,600	New	+$3.64M	0.01%	417
2021 Q1	–	Sell	-1,242	Closed	-$212K	–	697
2020 Q4	$212K	Sell	1,242 -758	-38%	-$112K	﹤0.01%	672
2020 Q3	$281K	Sell	2,000 -100	-5%	-$15.2K	﹤0.01%	664
2020 Q2	$337K	Buy	+2,100	New	+$286K	﹤0.01%	655

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s SRPT Position: Q4 2025 in Review

Caisse de Depot et Placement du Quebec (CDPQ) sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 66,000 shares — an estimated $1.27M sold.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in SRPT in Q2 2020 and held it in 7 quarters. The position peaked at $3.84M in Q4 2021. 347 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

Caisse de Depot et Placement du Quebec (CDPQ) reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
Caisse de Depot et Placement du Quebec (CDPQ) sold 66,000 Sarepta Therapeutics shares in Q4 2025, an estimated $1.27M.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Sarepta Therapeutics in Q2 2020 and held it in 7 quarters.
Caisse de Depot et Placement du Quebec (CDPQ)'s Sarepta Therapeutics position peaked at $3.84M in Q4 2021.
347 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q4 2025, filed 17 Feb 2026.